Higher mRNA expressions of BRD3/7/8/9 were significantly related to unfavorable OS of HCC patients, and patients with higher BRD7/8/9 expression levels had significantly shorter DFS. This evidence concerns the gene BRD3 and hepatocellular carcinoma.